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Abstract
Actinobacteria are found spread widely in nature and particular attention is given to their 
role in the production of various bioactive secondary metabolites. Tests on soil samples 
show that there can be a diversity of actinomycetes depending on the climate, the area it 
is growing in, how dry the soil is, and the quality of the soil. However, it was agreed after 
tests in Yunnan, China, that the genus Streptomyces sp. is most important in ecological 
function, representing up to 90% of all soil actinomycetes, and therefore helping to show 
the important characteristics needed of the soil actinomycete population. Streptomycete 
compounds are used for other biological activities, not just for antibiotics. It has been 
found that metabolites can be broadly divided into four classes: (1) regulatory activi-
ties in compounds, these include consideration of growth factors, morphogenic agents 
and siderophores, and plants promoting rhizobia; (2) antagonistic agents, these include 
antiprotozoans, antibacterials, antifungals, as well as antivirals; (3) agrobiologicals, these 
include insecticides, pesticides, and herbicides; and (4) pharmacological agents, these 
include neurological agents, immunomodulators, antitumorals, and enzyme inhibitors. It 
is found that Streptomyces hygroscopicus is one of the very best examples because it secretes 
in excess of 180 secondary metabolites to locate simultaneous bioactivities for a given 
compound. Increasingly, both its agricultural and pharmacological screenings are being 
used in conjunction with antimicrobial tests and have revealed several unusual aerobio-
logical and therapeutic agents, which were hitherto unknown for biological use as anti-
biotics. Since streptomycetes are now being used increasingly to screen for antimicrobial 
activity, reports show the existence of secondary metabolites with other activities that 
may have been missed. Currently, nearly 17% of biologically active secondary metabolites 
(nearly 7600 out of 43,000) are known from streptomycetes. It has been found that soil 
streptomycetes are the main source used by bioactive secondary metabolites. However, 
recently there have been many and varied types of structurally unique and biologically 
active secondary metabolites found and obtained from marine actinomycetes, including 
those from the genus Streptomyces. Also, compounds that are synthesized by streptomy-
cetes exhibit extreme chemical diversity. Diverse form made from  from simple amino acid  
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derivatives to high molecular weight proteides, and macrolactones from simple eight mem-
bered lactones to different condensed macrolactones. Berdy (1974) introduced the first 
classification scheme for antibiotics referring to the chemical structure. On the basis of 
Berdy’s scheme, (1996) recognized that both low and high molecular weight compounds 
from 63 different chemical classes are produced by streptomycetes.
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1. Introduction
Streptomyces are Gram-positive, filamentous bacteria belonging to the group actinomy-
cetes, a group that encompasses the majority of soil bacterial species. It is estimated that 
a gram of soil contains 109 CFU (colony-forming units) and out of these 109 CFUs, 107 are 
Actinobacteria [1]. They are ubiquitous soil bacteria, which are also found in the marine 
environment such as sediments [2]. Some are symbionts of sponges, for example, or insects 
like the ant Acromyrmex octospinosus, which lives in symbiosis with Streptomyces (Streptomyces 
S4)-producing antifungals, which help protect fungi cultivated by phytopathogenic ants [3]. 
Streptomyces have a particular development cycle. This cycle begins with a spore that ger-
minates forming vegetative hyphae very little septate that will be structured in a network, 
the vegetative mycelium whose role is to explore the environment in search of nutrients. 
The bacterium will form aerial hyphae compartmentalized during a deficiency in element 
nutrients; these hyphae will then differentiate into spores, which are the form of resistance 
and dissemination of this bacterium [4].
The production of many secondary metabolites, including antibiotics, is coupled with mor-
phological differentiation. Indeed, we observe a greater production of secondary metabolites 
during the transition from vegetative growth to aerial growth [5]. During this change in 
growth type, partial lysis of the mycelium vegetation takes place to provide the necessary 
nutrients for the creation of aerial mycelium; this release of nutrients could attract competi-
tors. This synchronization of the cycle of development and production of secondary metabo-
lites could be a way for the bacteria to dispel the invaders to keep these nutrients, or else kill 
the surrounding bacteria to feed them.
The secondary metabolite-producing microorganisms synthesize these bioactive and com-
plex molecules at the lag phase and stationary phase of their growth (Figure 1a). However, 
regarding actinomycetes and Streptomyces especially, secondary metabolites can be produced 
at exponential, stationary, and death phases [6, 7]. It appears in times of environmental issues 
that nutrient depletion-limiting growth conditions allow formation of secondary metabolites. 
These are mostly found in fungi, plants, soil, and marine environments and organisms. Its 
has also been found that different organisms can produce metabolites that have various bio-
logical abilities, which include metal transporting agents, sex hormones, toxins, pigments, 
pesticides, immunosuppressants, anticancer agents, antibacterial agents, immunomodulating 
agents, antagonists, and receptor antagonists. The intermediate or finished products of pri-
mary metabolic pathways are obtained from their own systematic pathways for the synthesis 
Basic Biology and Applications of Actinobacteria100
of secondary metabolites. To be able to obtain secondary metabolites, metabolic pathway 
reaction methods are conducted using multienzyme complexes or an individual enzyme. 
Genes that encode the synthetic pathway enzyme in general are within chromosomal DNA 
mostly arranged in cluster formation. As an example, Streptomycetes griseus and Streptomyces 
glaucescens chromosomal DNA contain 30 or more str/sts and blu genes that participate in 
streptomycin biosynthesis.
There are many varieties of known secondary metabolites synthesized by six pathways of 
different biosynthesis (Figure 1b): the peptide pathway, the polyketide synthase (PKS) path-
way, the nonribosomal polypeptide synthase (NRPS) pathway, the hybrid (nonribosmial 
polyketide synthetic) pathway, the shikimate pathway, the β-lactam synthetic pathway, and 
the carbohydrate pathway. The pathway peptide concerns a part of the protein secondary 
Figure 1. (a) Phases of bacterial growth and metabolite production. Overall, the major metabolites can be produced at the 
late interval phase and center of exponential phase, since the minor metabolites can be produced at the end of the stationary 
phase and during the constant phase. (b) Various pathways responsible for the assembly of secondary metabolites.
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metabolites: they are synthesized by simple translation of mRNAs into peptides by ribo-
somes. NRPSs are enzymes capable of condensing amino acids to form peptides without 
going through the ribosomal synthesis pathway. PKSs are enzymes capable of synthesizing a 
particular family of secondary metabolites: polyketides. The enzymes necessary for the syn-
thesis of these polyketides are homologous to fatty acid synthase (FAS), which is responsible 
for the synthesis of fatty acid chains. Like the FASs these enzymes can couple precursors to 
form a chain. This chain will then undergo eight post-PKS changes before becoming active. 
Regarding the carbohydrate (known scientifically as oligosaccharide) route, it is based on the 
use of enzymes capable of coupling different sugars to form a carbohydrate precursor; this 
chain will then undergo modifications that will make the precursor active [8].
2. Bioactivity of Streptomyces
Streptomyces produce 70–80% of the natural bioactive substances known for their pharma-
ceutical or agrochemical applications [9, 10]. Continuously new metabolites with different 
biological activities are isolated from Streptomyces strains [11–14]. The first and most impor-
tant product of Streptomyces is antibiotics [15]. From 1955 the genus Streptomyces has been 
the major supplier of new antibiotics [16]. They are the source of antibacterial, antifungal, 
antitumor, antiparasitic [17–19], antiviral, insecticide, pesticide, and herbicide substances, in 
addition to pharmacological substances such as immunomodulators (immunosuppressive 
and immunostimulatory agents), vasoactive substances, and neurological agents [20].
Enzymes are the most important products of Streptomyces after antibiotics [21], such as prote-
ases, lipases, cellulases, amylases, pectinases, and xylanases [22, 23].
2.1. Production of antibiotics by Streptomyces
2.1.1. General
Antibiotics are produced by a wide range of fungal microorganisms and bacteria, and inhibit 
or kill other microorganisms at low concentrations [24]. A large number of antibiotics have 
been identified in natural environments, but less than 1% are medically useful. Many antibiot-
ics have been structurally modified in the laboratory to increase their effectiveness, forming 
the class of semisynthetic antibiotics [25].
The history of antibiotics began with the discovery of penicillin by Fleming in the 1940s. The 
antimicrobial activities of antibiotics produced by microorganisms have been extensively 
studied, and the research undertaken has allowed completion of the antibacterial arsenal 
available to doctors and the general public.
Microorganisms producing chloramphenicol, neomycin, tetracycline, and terramycin were 
isolated in 1953. The discovery of chemotherapeutic agents and the development of new, 
more powerful drugs revolutionized medicine and have greatly reduced human suffering 
[26]. It is very well known that the genus Streptomyces produces the majority of antibiot-
ics and biologically active secondary metabolites. Nearly 50% of the species Streptomyces 
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isolated are recognized as producers of antibiotics [25]. Actinomycetes synthesize two-thirds 
of the microbial antibiotics of which about 80% are isolated from the genus Streptomyces. 
Even if other secondary metabolites are included, the actinomycetes remain the largest 
suppliers with about 60% (Streptomyces always have the biggest part with 80%). More than 
60 substances with antibiotic activity produced by Streptomyces species are used not only 
in the world of veterinary and human medicine, but also in the field of agriculture and 
industry. The capacity of the members of the genus Streptomyces [27, 28] to produce com-
mercially significant compounds, especially antibiotics, remains unsurpassed, possibly 
because of the extra-large DNA complement of these bacteria [17]. Antibiotics that come 
from Actinobacteria are grouped together so that they belong in their major structural 
classes. Examples of these are ansamycins (ritamycin), macrolides (erythromycin, azithro-
mycin, and clarithromycin), aminoglycosides (streptomycin, kanamycin, tobramycin, genta-
micin, and neomycin), tetracyclines, anthracyclines (doxorubicin), and β-lactam (penicillin, 
cephalosporin, carbapenems, and monobactams). Streptomycin and its varying species 
strains have been responsible for the production of most antibiotics and it appears that these 
organisms produce antibiotics to kill off potential competitors [29]. Streptomycin was one 
of the first antibiotics found. It is produced by S. griseus [30]. Today, various Streptomyces 
species are responsible for approximately 75% of both medical and commercial antibiot-
ics and work very well in these areas. Due to the need for new antibiotics, studies have 
steered towards the isolation of streptomycetes and the careful screening of different habi-
tats in which they are used. It has also been found through research that different condi-
tions such as nutrients, culturing, and other factors may affect how Streptomyces develop 
to form antibiotics. With this in mind the medium constitution along with metabolic capac-
ity of any organism production can affect antibiotic biosynthesis. Research into actinomy-
cetes has found that they are capable of producing more one antibiotic (e.g. S. griseus and 
S. hygroscopicus) and also the same antibiotic can produce various species of Actinobacteria 
(e.g. streptothricin and actinomycin). Therefore, an antibiotic may be exactly the same with 
the same chemical composition and antibiotic spectrum as a produced Actinobacterium 
(Table 1). The table gives a list of antibiotics produced by variations of Actinobacteria and 
how the antimicrobial application has had a profound impact on the medical world where 
previously cancers, tumors, and even malaria could not be treated.
2.2. Production of enzymes
Research has reported that there are a great variety of enzymes that can be applied to biomicro-
bial fields and biotechnological industries from different genera of actinomycetes. Using the 
information available from genome and protein sequencing data, actinomycetes are constantly 
screened and used for producing amylases, xylanases, proteases, chitinases, cellulases, and 
other enzymes. Industrial applications, for example, the pronase of S. griseus and the kerase of 
Streptomyces fradiae, are used for the commercial production of biotechnology products such 
as hydrolysate proteins from different protein sources [31]. The proteases of Streptomyces have 
the advantage of easy elimination of the mycelium by filtration or simple centrifugation [32]. 
Similarly, Actinobacteria have been revealed to be an excellent resource for L-asparginase, 
which is produced by a range of Actinobacteria, mainly those from soils such as S. griseus, 
Streptomyces karnatakensis, Streptomyces albidoflavus, and Nocardia spp. [33, 34] (Table 2).
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Antibiotic compound Streptomyces species Application
1,4-Dihydroxy-2-(3-hydroxybutyl)-
9,10-anthraquinone 9,10 anthrac
Streptomyces sp. RAUACT-1 Antibacterial
1,8-Dihydroxy-2-ethyl-3-
methylanthraquinone
Streptomyces sp. Antitumor
2-Allyloxyphenol Streptomyces sp. Antimicrobial; food preservative; oral 
disinfectant
Anthracyclines S. galileus Antitumor
Arenimycin S. arenicola Antibacterial; anticancer
Avermectin S. avermitilis Antiparasitic
Bafilomycin S. griseus, S. halstedii ATPase; inhibitor of microorganisms, plant 
and animal cells
Bisanthraquinone Streptomyces sp. Antibacterial
Carboxamycin Streptomyces sp. Antibacterial; anticancer
Chinikomycin Streptomyces sp. Anticancer
Chloramphenicol S. venezuelae Antibacterial; inhibitor of protein 
biosynthesis
Chromomycin B, A2, A3 S. coelicolor Antitumor
Daryamides Streptomyces sp. Antifungal; anticancer
Elaiomycins B and C Streptomyces sp. BK 190 Antitumor
Frigocyclinone S. griseus Antibacterial
Glaciapyrroles Streptomyces sp. Antibacterial
Hygromycin S. hygroscopicus Antimicrobial; immunosuppressive
Lajollamycin S. nodosus Antibacterial
Lincomycin S. lincolnensis Antibacterial; inhibitor of protein 
biosynthesis
Mitomycin C S. lavendulae Antitumor; binds to double-stranded DNA
Pacificanones A and B S. pacifica Antibacterial
Piericidins Streptomyces sp. Antitumor
Proximicins Verrucosispora sp. Antibacterial; anticancer
Pristinamycine S. pristinaespiralis Antibacterial
Rapamycin S. hygroscopicus Immunosuppressive; antifungal
Resistoflavin methyl ether Streptomyces sp. Antibacterial; antioxidative
Saliniketal S. arenicola Cancer; chemoprevention
Salinispyrone S. pacifica Unknown
Salinispyrone A and B S. pacifica Mild cytotoxicity
Salinosporamide A Salinispora tropica Anticancer; antimalarial
Salinosporamide B and C S. tropica Cytotoxicity
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Antibiotic compound Streptomyces species Application
Sesquiterpene Streptomyces sp. Unknown
Staurosporinone Streptomyces sp. Antitumor; phycotoxicity
Streptokordin Streptomyces sp. Antitumor
Streptomycin S. griseus Antimicrobial
Streptozotocin S. achromogenes Diabetogenic
Tetracyclines Streptomyces achromogenes; S. 
rimosus
Antimicrobial
Tirandamycins Streptomyces sp. Antibacterial
Valinomycin S. griseus Ionophor; toxic for prokarotes, eukaryotes
Table 1. List of antibiotics produced by different  Actinobacteria  and their applications.
Enzyme Industry Use Streptomyces strains
Aminoacylase Pharmaceuticals Production of semisynthetic 
penicillins and celpholosorin
S. olivaceus
S. roseiscleroticus
S. sparsogenes
Amylase Detergent Removal of stains Streptomyces sp.
Baking Softening of bread; volume S. erumpons
Paper and pulp Deinking
Drainage improvement
Starch Production of glucose, 
fructose, syrups
Textile Removal of starch from woven 
fabrics
Cellulase Detergent Removal of stains S. thermobifida,
Textile Denim finishing, softening of 
cotton 
halotolerans, S.
Paper and pulp Deinking, modification of 
fibers
thermomonospora, S. ruber
Chitinase Bioremediation Utilization of chitin waste S. griseus
S. antibioctius
Glucose oxidase Baking Strengthening of dough S. coelicolor
Keratinase
Laccase Bleaching Clarification (juice), flavor 
(beer), cork stopper treatment
S. brahimensis
L-Asparaginase Medicine The treatment of acute 
lymphoblastic leukemia
S. karnatakensis
S. halstedii
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http://dx.doi.org/10.5772/intechopen.79890
105
Enzyme Industry Use Streptomyces strains
Lipase Detergent Removal of stains S. griseus
Baking Stability of dough
Dairy Cheese flavoring
Textile Deinking, cleaning
N-Acetylmuramidase Bacteriology Bacteriostatic enzymes S. globisporus
Neuraminidase Medical research Cell surface and clinical studies Streptomyces sp.
Pectinase Beverage Clarification, mashing S. lydicus
Textile Scouring
Penicillin amidase Commercial significance Production of 
6-aminopenicillanic acid on an 
industrial scale
Streptomyces sp.
Peptide hydrolase Pharmaceuticals Industrial biosynthesis of 
oxytetracycline
S. rimosus
Phytase Animal feed Phytate digestibility S. luteogriseus R10
Protease Food Cheese making S. pactum, S.
Brewing Clarification; low calorie beer thermoviolaceus, Streptomyces 
sp.
Leather Dehiding
Medicine Treatment of blood clot
Tyrosinase Pharmacy L-Dopa synthesis S. cyaneofuscatus
Xylanase Baking Conditioning of dough Streptomyces spp.
Animal feed Digestibility
Paper and pulp Bleach boosting
β-N-Acetyl-D-
glucosaminidase
Studying their 
biochemical functions
Structural determination of the 
carbohydrate moiety of several 
glycoproteins
S. griseus
Table 2. List of enzymes produced by various Actinobacteria and their industrial application.
2.3. Bioherbicides
Secondary metabolites of Actinobacteria are used as herbicides against unwanted herbs and 
weeds (Table 3).
2.4. Probiotics
The use of Streptomyces sp. on the growth of tiger shrimp has been previously documented. Also, 
it was found that antibiotic product extracted from marine Actinobacteria and supplemented 
in feed was efficient in exhibiting the in vivo effect on feed and the detection of the efficient 
effect of in vivo white spot syndrome virus in black tiger shrimp. The murine actinomycete 
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activity was found to be an effective microorganism against biofilms resulting from Vibrio spp., 
suggesting therefore the potential preventive effect of Actinobacteria against Vibrio deseases 
[35]. Moreover, Latha [36] identified 18 Actinobacteria with probiotic properties isolated from 
chicken, and their results support the potential preventive effect of Streptomyces sp. JD9 as 
probiotic agents against deseases.
2.5. Aggregative peptide pheromones
The production of pheromone is considered to have important criteria: it is used as a defense 
against predators, in mate selection, and to conquer host-habitats through mass attack. Sex 
pheromone peptides in culture supernantrants were mainly found to support aggregation 
together by the same related species [37, 38]. A good example for aggregative peptide phero-
mones is Streptomyces werraensis LD22, which secretes a heat-stable, acidic pH resistant, low 
molecular weight peptide pheromone that promotes aggregation propensity and enhances 
the biofilm-forming ability of other Actinobacterial isolates.
2.6. Biosurfactants
Microbially derived compounds that share hydrophilic and hydrophobic moieties are surface 
active biosurfactants that are independent of mineral oil as a feedstock compared with chemi-
cally derived surfactants.
Biosurfactants are widely used in scientific research topics (nutrients, cosmetics, textiles, 
varnishes, pharmaceuticals, mining, and oil recovery) [39, 40]. The lipopeptide antibiotic dap-
tomycin has received great interest as a treatment for Gram-positive bacterial infections; it is 
marketed as Cubicin by Cubist Pharmaceuticals. Various biosurfactant drugs or bioemulsifi-
ers have been described as a class of Actinobacteria. The best described biosurfactants include 
a class of glucose-based glycolipids, most of which have a hydrophilic backbone, including 
glycosides associated with glucose units forming a trehalose moiety.
Bioherbicides Biocontrol Streptomyces strains
Anisomycin Inhibitor of growth of annual grassy weeds such  
as barnyardness and common crabgrass and broad-
leaved weeds
Streptomyces sp.
Bialaphos Control of annual and perennial grassy weeds and 
broad-leaved weeds
S. viridochromogenes
Carbocyclic coformycin and 
hydantocidin
Control of several weeds S. hygroscopicus
Herbicidines and 
herbimycins
Monocotyledonous and dicotyledonous weed S. saganonensis
Phthoxazolin, hydantocidin, 
and homoalanosin
Control of several weeds Streptomyces sp.
Table 3. Exemles of herbicides produced by actinobacteria used against unwanted herbs and weeds.
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Pigments Streptomyces strain Class
III Undecylprodigiosin S. longispororuber DSM 40599 Prodigiosin
IV Metacycloprodigiosin
Actinomycin Streptomyces sp. Phenoxazinone
Granaticin S. litmocidin DSM 40164 Naphthoquinone
Rhodomycin Synodontis violaceus DSM 40704 Anthracycline glycoside
Table 4. Exemples of pigments produced by some streptomyces species and their classification.
2.7. Vitamins
Vitamin B12 or cobalamine can be synthesized through the fermentation of Actinobacteria [41, 
42], and has aroused considerable interest in the possible production of vitamins through micro-
bial fermentation. In addition, cobalt salts in media act as a general Actinobacteria precursor in 
producing vitamins. Because cobalt is a rather effective bactericidal agent, this precursor must 
be added carefully. The fermentations producing the antibiotics streptomycin, aureomycin, 
grisein, and neomycin produce vitamin B12 as well if the medium is supplemented with cobalt 
without affecting the yields of antibiotic substances.
2.8. Pigments
Microbe-oriented pigments are of great concern. Especially, Actinobacteria are characterized by 
the production of various pigments on natural or synthetic media and are considered an impor-
tant cultural characteristic in describing the organisms. Generally, the morphological features 
of colonies and production of different pigments and aerial branching filaments are known as 
hyphae, giving them a fuzzy appearance. These pigments are usually various shades of blue, 
violet, red, rose, yellow, green, brown, and black, which can be dissolved in the medium or may 
be retained in the mycelium. These microbes also have the ability to synthesize and excrete dark 
pigments, melanin or melanoid, which are considered useful criteria for taxonomical studies in 
the textile industry (Table 4).
2.9. Nanoparticle synthesis
The chemical techniques of nanoparticle preparation are less expensive when produced in 
high quantities; however, the nanoparticles may be contaminated by precursor chemicals, 
toxic solvents, and risky by-products. As a result, the development of high-yield, low-charge, 
nontoxic effects, and beneficial environmental procedures for metallic nanoparticle syn-
thesis, and thus the biological method of nanoparticle synthesis, is considered important. 
Actinobacteria are actually effective nanoparticle producers, showing a number of biological 
properties, including antibacterial, antifungal, anticancer, antibiofouling, antimalarial, anti-
parasitic, and antioxidant activities. Streptomyces and Arthrobacter genera have proved to be 
“nanofactories” for developing clean and nontoxic procedures for the preparation of silver 
and gold nanoparticles (Table 5).
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2.10. Bioremediation
Streptomyces have an important role in the recycling of organic carbon and are able to degrade 
complex polymers [43]. As reported, the wide use of petroleum hydrocarbons as chemical 
compounds and fuel in everyday life was considered well-known pollutants of large soil sur-
faces, causing serious environmental damage. Some studies proved the possible beneficial 
role of Streptomyces flora in the degradation of hydrocarbons [44, 45]. Many Actinobacterial 
strains are able to solubilize lignin and break down lignin-related compounds following the 
production of cellulose and hemicellulose-degrading enzymes and extracellular peroxidase 
[46]. Actinobacteria species are able to grow and live in oil-rich environments, and thus they 
could be in bioremediation to reduce oil contaminants.
2.11. Control of plant diseases
Results of new approaches to control plant diseases. Actinobacteria are potentially used in the 
agro-industry as a source of agroactive compounds of plant growth (rhizobacteria (polyglyc-
erol polyricinoleate, PGPR) promoting) and for biocontrol [47, 48]. Approximately 60% of the 
new insecticides and herbicides derived from Streptomyces were discovered in the last 5 years. 
Kasugamycin, a bactericidal and fungicidal metabolite discovered in Streptomyces kasugaensis 
[49], inhibits protein biosynthesis in microorganisms but not in mammals, since its toxicologi-
cal features are excellent. Inhibition of plant pathogenic Rhizoctonia solani under in vitro condi-
tions was assessed with the culture supernatant of Streptomyces sp., which showed that the 
tested Actinobacteria had the ability to reduce damping-off severity in tomato plants (Table 6).
2.12. Nematode control
The majority of microorganisms were identified as antagonists of plant-parasitic nematodes, 
in particular Actinobacteria, which are effectively used in biological control because of their 
ability to produce antibiotics. The Streptomyces species-producing avermectins show that high 
nematicidal compounds can be produced by soil-borne organisms. Streptomyces avermitilis 
produces ivermectin, having an efficient activity against Wucheria bancroftii [50]. Similarly, 
various other antiparasitic compounds are produced from various Streptomyces sp.
2.13. Enhancement of plant growth
PGPR can directly or indirectly affect the growth of plants in two common ways. Indirect 
growth happens when PGPR decreases or prevents the harmful effects of one or more damaging 
Streptomyces strains Nanoparticles
Streptomyces sp. GRD, Streptomyces sp., S. albidoflavus, S. 
hygroscopicus, S. rochei
Silver
S. aureofaciens, S. glaucus, S. viridogens, S. hygroscopicus Gold
Streptomyces sp. Zinc, copper, manganese
Table 5. Exemples of nanoparticules produced by some streptomyces species.
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microorganisms. This is mainly researched through biocontrol or the antagonism of soil plant 
pathogens. Particularly, the effects of pathogen invasion and establishment can be strongly pre-
vented by colonization or the biosynthesis of antibiotics and other secondary metabolites. Direct 
growth promotes plant growth by PGPR when the plant is supplied with a bacterial synthesized 
compound, or when PGPR otherwise facilitates plant uptake of soil nutrients. Merriman [51] 
reported the use of S. griseus for seed treatment of barley, oat, wheat, and carrot to increase their 
growth. The isolate was originally selected for the biological control of Rhizoctonia solani. It has been 
reported that Streptomyces pulcher, Streptomyces canescens, and Streptomyces citreofluores were used in 
the control of bacterial, Fusarium, and Verticillium wilts, early blight, and bacterial canker of tomato.
Like most rhizobacteria, it seems highly probable that streptomycetes are capable of directly 
enhancing plant growth.
2.14. Phytohormone production
Manulis et al. [52] described plant hormone production, including indole-3-acetic acid (IAA), as 
well as the underlying pathways of synthesis by a variety of Streptomyces spp. (Streptomyces viola-
ceus, Streptomyces scabies, S. griseus, Streptomyces exfoliatus, Streptomyces coelicolor, and S. lividans), 
Disease Streptomyces strains Antibiotic produced
Asparagus root diseases S. griseus Faeriefungin
Blotch of wheat S. malaysiensis Malayamycin
Broad range of plant diseases S. griseochromogenes Blasticidin S
Brown rust of wheat S. hygroscopicus Gopalamycin
Damping-off of cabbage S. padanus Fungichromin
Grass seedling disease S. violaceusniger YCED9 Nigericin and guanidylfungin A
Phytophthora blight of pepper S. humidus Phenylacetic acid
Phytophthora blight of pepper S. violaceusniger Tubercidin
Potato scab S. melanosporofaciens Geldanamycin
EF-76 and FP-54
Powdery mildew Streptoverticillium rimofaciens Mildiomycin
Powdery mildew of cucumber Streptomyces sp. KNF2047 Neopeptin A and B
Rice blast disease S. kasugaensis Kasugamycin
Rice sheath blight S. cacaoi var. Asoensis Polyoxin B and D
Root rot of pea geldanus S. hygroscopicus Geldanamycin
Sheath blight of rice S. hygroscopicus var. Limoneus No. T-7545 Validamycin
Table 6. Antibiotics produced by the Actinobacteria that suppress various plant diseases.
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since earlier works have studied the IAA synthesis process in Streptomyces spp. This was the 
first investigation confirming IAA production according to new analytical methods, i.e. high-
performance liquid chromatography and gas chromatography–mass spectrometry. Furthermore, 
Manulis et al. [53] described well the biosynthetic pathways of IAA in Streptomyces. On the other 
hand, Aldesuquy et al. [54] studied the effect of streptomycetes culture filtrates on wheat growth, 
showing a subesquent significant increase in shoot fresh mass, dry mass, length, and diameter 
statistically exhibited with some bacterial strains at different sample times. Streptomyces olivaceo-
viridis revealed a remarkable effect on yield components (spikelet number, spike length, and fresh 
and dry mass of the developing grain) of wheat plants. This activity may result from the increase 
in phytohormone bioavailability defined as PGPR produced, since all PGPR strains (Streptomyces 
rimosus, Streptomyces rochei, and S. olivaceoviridis) produce significant amounts of auxins (IAA), 
gibberellins, and cytokinins.
2.15. Biolarvicides
Dhanasekaran et al. [55] obtained that the isolates Streptomyces sp., Streptosporangium sp., and 
Micropolyspora sp. presented with great larvicidal activity against Anopheles mosquito larvae. 
Rajesh et al. [56] prepared silver nanoparticles from Streptomyces sp. GRD cell filtrate and 
found remarkable larvicidal activity against Aedes and Culex vectors, causing transmission of 
dengue and filariasis. In addition, studies carried out on the larvicidal effect of Actinobacterial 
extracts against Culex larvae have shown that a concentration of 1000 ppm of the isolate 
Streptomyces sp. appeared as KA13-3 with 100% mortality and KA25-A with 90% mortality. 
Other secondary metabolites obtained from Actinobacteria (tetranectin [56], avermectins [57], 
macrotetrolides [58], and flavonoids [59]) are classified as toxic to mosquitoes.
2.16. Odor and flavor compound production
The work carried out by Gaines and Collins [60] on the metabolites of Streptomyces odorifer 
led them to conclude that the earthy odor is likely due to a combination of trivial compounds 
(acetic acid, acetaldehyde, ethyl alcohol, isobutyl alcohol, isobutyl acetate, and ammonia). 
Consequently, other components contributing to the odor could also be produced. Several 
odor-producing compounds have been defined from Actinobacteria (Table 7). Earthy odors 
in sufficiently treated water supplies led to considerable interest from consumers, who may 
classify water with these odors as harmful for human drinking needs. These odors are the 
second most common cause of odor problems recorded by water utilities, behind chlorine.
Streptomyces strain Odor type Secondary metabolite
Streptomyces sp. Earthy Trans-1,10-dimethyl-trans-9-decalol (geosmin)
Musty 1,2,7,7-Tetramethyl-2-norbornanol
Potato-like 2-Isobutyl-3-methoxypyrazine or 
2-isopropyl-3-methoxypyrazine
Table 7. Odor-producing compounds from Actinobacteria.
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Figure 2. Minimum domains required in an NRPS [62].
3. Metabolic pathways in the production of secondary metabolites of 
bacteria
Secondary metabolic pathway reactions are formed by an individual enzyme or multienzyme 
complexes. Intermediate or end products of primary metabolic pathways are channeled from 
their systematic metabolic pathways that lead to the synthesis of secondary metabolites. There 
are six known pathways: the peptide pathway, the PKS pathway, the NRPS pathway, the 
hybrid (nonribosomal polyketide) synthetic pathway, the shikimate pathway, the β-lactam 
synthetic pathway, and the carbohydrate pathway. The genes encoding these synthetic path-
way enzymes are generally present in chromosomal DNA and are often arranged in clusters.
3.1. Nonribosomal peptide synthesis pathways
Nonribosomal peptides are peptides that are not synthesized at the level of ribosomes. One of 
the peculiarities of nonribosomal peptides is their small size. These peptides are not encoded 
by a gene, and they are not limited to the 20 basic amino acids. Indeed, the peculiarity of the 
NRPS system is the ability to synthesize peptides containing proteinogenic and nonproteino-
genic amino acids. In many cases, these enzymes are activated in collaboration with polyk-
etone synthases giving hybrid products. The products of these multifunctional enzymes have 
a broad spectrum of biological activities, and some of them have been useful for medicine, 
agriculture, and biological research [61].
NRPS are organized in a modular way. Each module is responsible for the incorporation of a 
specific monomer. The modules are subdivided into domains, and each domain catalyzes a 
specific reaction in the incorporation of a monomer. The number and order of modules and 
the type of domain present in the modules of each NRPS determine the structural variation 
of synthesized peptides by dictating the number, order, and choice of amino acid to incorpo-
rate during elongation. Four main areas are needed for complete synthesis (Figure 2). Each 
domain has a specific function when incorporating the monomer. Domain A, from 500 to 600 
amino acid residues, is necessary for the recognition of the amino acid and its activation.
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The 80–100 amino acid residues of domain T, located downstream of domain A, form a thioes-
ter bond (covalent bond) between the activated monomer and the NRPS, and this allows the 
peptide being synthesized to remain attached to the NRPS throughout the process of elonga-
tion. The condensation domain C (450 amino acids) is usually found after each A–T module 
and catalyzes the formation of peptide bonds between bound residues on two adjacent mod-
ules. In general, the number and order of modules present in an NRPS determine the length 
and the resulting nonribosomal peptide structure. The thioesterase domain, present only in 
the last module, releases the peptide from the NRPS.
3.2. Polyketide synthase pathways
Polyketides are kown as natural products, having diverse functions in medical applications, 
and they are assembled by PKS enzymes. PKS enzymes act exactly like fatty acid synthase to 
generate a diverse extent of polyketides. Also, PKS enzymes start the polyketide assembly 
by priming the initiator molecule to the catalytic residue, and then making an extender unit 
for the elongation chain. On the basis of structural architecture and variation in enzymatic 
mechanism, PKS enzymes have been classified into three types: (1) type I PKS, (2) type II PKS, 
and (3) type III PKS.
This section describes all three types of PKS enzymes (Table 8). Modular PKSs include active 
sites, called modules; they are polypeptides used to synthesize a string of carbon. The active 
sites of each module are used only once during assembly of the molecule and determine the 
choice of units of structure and the level of reduction or dehydration for the cycle of expan-
sion. They catalyze the length of the string of carbon, and the number of cycles of reaction 
is determined by the number and order of the modules in the polypeptide constituting the 
PKS [63].
3.2.1. Type I PKS
These are multidomain proteins (containing several domain enzymes on the same polypep-
tide) that can be modular (Figure 3), for example, the modular systems responsible for the 
synthesis of macrolides (erythromycin, rapamycin, rifamycin B, etc.) in bacteria, which is 
iterative (Figure 4) (for example, lovastatin nonaketide).
Either modular PKS or type I Either discrete PKS or type II Either ketosynthase polyketide or type 
III
Many functional enzymes organized 
into modules. Each module has a 
specific function and use; acyl carrier 
protein (ACP) domain activates 
acyl-CoA substrates malonyl-CoA or 
methylmalonyl-CoA or ethylmalonyl-
CoA, an extender unit
Includes a series of modular 
heterodimeric enzymes. Each 
enzyme has a special function 
and use; the ACP domain 
transfers activated acyl-CoA 
substrate malonyl-CoA, an 
extender unit
The homodimeric ketosynthase enzyme 
can carry out various biochemical 
reactions at a single active site; it acts in 
the absence of ACP or directly recognizes 
the acyl-CoA molecules malonyl-CoA or 
methylmalonyl-CoA, an extender unit
Table 8. Classification of polyketide synthase enzymes and the functional and mechanistic differences between them.
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Figure 4. Structure of an iterative type I PKS [65].
3.2.2. Type II PKS
These are monofunctional protein complexes (for example, actinorhodin from S. coelicolor). 
These PKSs catalyze the formation of compounds that require aromatization and cyclization 
steps but no reduction or dehydration. These PKSs are involved in the biosynthesis of aro-
matic bacterial products such as actinorhodin, tetracenomycin, and doxorubicin [66].
3.2.3. Type III PKS
These have a single active site to catalyze the extension of the polyketide chain and cyclization 
without the use of an ACP (Figure 5). They are responsible for the synthesis of chalcones and 
stilbenes in plants, as well as polyhydroxy phenols in bacteria. Chalcone synthases are small 
Figure 3. Structure of a modular type I PKS [64]. Note: KS, ketosynthase; AT, acyl transferase; KR, ketoreductase; ACP, 
acyl carrier protein; TE, Thioesterase; DH, dehydrate.
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proteins with a unique polypeptide chain, and are involved in the biosynthesis of flavonoid 
precursors [67].
The shikimate pathway groups the essential building blocks for a large assembly of aromatic 
metabolites and amino acids. Metabolites of the aromatic compounds present protection against 
ultraviolet radiation, electron transport, and signaling molecules, and also act as antibacterial 
agents. The shikimate pathway enzymes use specific chemical substrates, i.e. erythrose-4-phos-
phate and phosphoenol pyruvate (primary metabolites), to start the synthesis of aromatic building 
blocks. Herein, the first seven enzymes catalyze the chemical reactions in a chronological manner 
to produce chorismate. Two bacterial enzymes are able to transfer a complete enolpyruvoyl moi-
ety to a metabolic pathway. 5-Enolpyruvoyl shikimate 3-phosphate synthase is considered one 
of the shikimate pathways. Chorismate synthase is an enzyme involved in this pathway, and its 
function needs the presence of a reduced cofactor, flavin mononucleotide, for its activation [69].
The Gram-positive, filamentous Streptomyces venezuelae (soil bacterium) and other actinomy-
cetes gather chloramphenicol with the help of aromatic precursors. Aromatic building blocks 
originated from the shikimate pathway act as precursors for the phenylpropanoid unit of 
chloramphenicol. First, chorismic acid branches out from the shikimate pathway to produce 
p-aminophenylalanine, which could afterwards be converted into a p-nitrophenylserinol 
component by an enzymatic reaction. 4-Amino-4-deoxychorismic acid (ADC) was found as 
a common precursor for both para-aminobenzoic acid and PAPA: a flexible tool for iden-
tifying pleiotropic pathways using genome-wide association study summaries pathways. 
The genetic map reveals that pabAB genes encode enzymes for ADC biosynthesis that are 
clustered in a distinct region of the S. venezuelae chromosome. Echinosporin isolated from 
Saccharopolyspora erythraea has antibacterial and anticancer activities. This molecule has a 
sole tricyclic acetal-lactone structure, and the main structure does not show its biosynthetic 
pathway. The shikimate pathway intermediate is guided to group the echinosporin by enzy-
matic reactions [70].
3.3. Lactam ring synthetic pathways
Cephalosporins belong to the family of β-lactam antibiotics, used for treating bacterial infec-
tions for more than 40 years. Interestingly, Gram-positive bacteria, Gram-negative bacteria, 
Figure 5. Type III PKS [68].
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and fungi are the major sources of β-lactam antibiotics. The Gram-positive Streptomyces cla-
vuligerus is able to produce both clavulanic acid and cephamycin, since the Gram-negative 
bacterium Lysobacter lactamgenus produces cephabacins. Two hypotheses have been put for-
ward for β-lactam biosynthesis: (1) horizontal gene transfer (HGT) from bacteria to fungi and 
(2) vertical descent (originated from a common ancestor). Bioinformatics, genetic designs, 
and sequence identity are more beneficial in HGT.
The production of β-lactam antibiotic occurs through three different steps: prebiosynthetic steps, 
intermediate formation steps, and late steps (also known as decorating steps) [71–76]. The biosyn-
thesis of building blocks for β-lactam consist of L-α-aminoadipic acid, L-cysteine, and L-valine. 
L-α-Aminoadipic acid is not a proteinogenic amino acid formed from L-lysine. The actinomycete 
lysine 6-aminotransferase converts L-lysine into L-α-aminoadipic acid.
The two starting enzyme reactions are omnipresent in fungi and cephalosporin biosynthesis. 
D-(L-Aminoadipyl)-L-cysteinyl-D-valine synthase is the first enzyme, using all three amino 
acids gathered into a tripeptide through condensation reaction. This enzyme is NRPS encoded 
by the acvA (pcbAB) gene. The next step is the synthesis of a bicyclic ring (a four-member 
β-ring is fused with a five-member thiazolidine ring) through an oxidative reaction, catalyzed 
by isopencillin N-synthase, and results in the formation of isopenicillin N. Cephalosporin–
cephamycin biosynthesis is the development of the five-member thiazolidine ring into a 
six-member dihydrothiazine ring. Several enzymes consecutively contribute to this ring con-
version. β--Lactam biosynthesis is synthesized by a gene, which is usually clustered in the 
DNA of all reproducing bacteria. Bacterial species capable of producing β--lactam antibiotics 
exhibit an ecological benefit. In contrast, β-lactam–producing bacteria show low sensitivity to 
β-lactams on their own, or they have evolved to inactivate β-lactam antibiotics by β-lactamase 
enzymes.
4. Conclusion
Streptomyces are able to produce a number of antibiotics and other important pharmaceuti-
cal drugs to treat infections caused by bacteria and fungi, cancer, and heart-related diseases. 
Bacterial species reveal a complex lifecycle with physiological and biochemical adaptabil-
ity, along with the ability to synthesize a large variety of secondary metabolites, presenting 
complex structures following different metabolic pathways. Understanding the secondary 
metabolite biosynthesis and pathways would lead to progress in combinatorial biosynthesis 
in the pharmaceutical and biotechnology industries.
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